Breast

This educational activity will focus on the radiation therapy treatment scenarios commonly faced in practice; i.e.,  breast radiation for early stage disease undergoing breast conservation and regional nodal irradiation for node positive breast cancer.  Breast radiation following lumpectomy for ductal carcinoma in situ and early invasive breast cancer including whole breast irradiation; partial breast irradiation and observation, as well as the clinical trial data supporting treatment effectiveness, will be reviewed.  This educational activity will also focus on the evidence, indications and methodology for regional nodal irradiation post mastectomy or lumpectomy in breast cancer patients with 1-3  axillary nodal metastasis in the setting of adjuvant systemic therapy.  Regional nodal irradiation in the post neoadjuvant systemic therapy setting will be reviewed as well. 

Target Audience

The activity is designed to meet the interests of practicing radiation oncologists, radiation oncology residents, medical and clinical physicists, nurses and all other health professionals involved in the field of radiation oncology.
 

Learning Objectives

Upon completion of this live activity, attendees should be able to do the following:
1.    Identify current acceptable radiation methods and suitable patient populations for breast conserving treatment in early stage invasive and non-invasive breast cancer.  
2.    Describe the rationale and indications for regional nodal irradiation post mastectomy and lumpectomy for node positive breast cancer in the setting of adjuvant and neoadjuvant systemic therapy
3.    Recognize radiation methods that maximize the therapeutic ratio by minimizing toxicity from breast conserving therapy in early stage disease and regional nodal irradiation in node positive disease.  

 

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.50 Certificate of Attendance
    This activity was designated for 1.50 AMA PRA Category 1 Credit™.
Course opens: 
04/07/2020
Course expires: 
04/06/2023
Cost:
$0.00
Part of: 
2020 ASTRO Annual Refresher Course - onDemand
Rating: 
0

Julia White, MD, FASTRO, is employed by The Ohio State University and has no other disclosure to declare.

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.

 

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.50 Certificate of Attendance
    This activity was designated for 1.50 AMA PRA Category 1 Credit™.

Price

Cost:
$0.00
Please login or register to take this course.